Literature DB >> 7901480

Recurrence of Rift Valley fever in Egypt.

R R Arthur1, M S el-Sharkawy, S E Cope, B A Botros, S Oun, J C Morrill, R E Shope, R G Hibbs, M A Darwish, I Z Imam.   

Abstract

Rift Valley fever (RVF) has been recorded in man and in domestic animals in Egypt after a 12-year absence. Human infections were first noted in the Aswan Governorate in late May, 1993. Only cases of ocular disease, an infrequent and late manifestation, were reported. Of 41 cases, 35 were tested serologically and 27 (77%) had RVF virus-specific IgM antibodies. An estimated 600-1500 infections occurred in the region. Abortions in cattle and buffalo were seen concurrently and antibodies to RVFV were present in 39% of domestic livestock, presumably unvaccinated. RVFV was isolated from an aborted water buffalo fetus.

Entities:  

Mesh:

Year:  1993        PMID: 7901480     DOI: 10.1016/0140-6736(93)92128-g

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  31 in total

1.  Genetic reassortment of Rift Valley fever virus in nature.

Authors:  A A Sall; P M Zanotto; O K Sene; H G Zeller; J P Digoutte; Y Thiongane; M Bouloy
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Systematic Review of Important Viral Diseases in Africa in Light of the 'One Health' Concept.

Authors:  Ravendra P Chauhan; Zelalem G Dessie; Ayman Noreddin; Mohamed E El Zowalaty
Journal:  Pathogens       Date:  2020-04-20

Review 3.  Emerging infectious diseases: the Bunyaviridae.

Authors:  Samantha S Soldan; Francisco González-Scarano
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

4.  Prevalence of anti-Rift-Valley-fever IgM antibody in abattoir workers in the Nile delta during the 1993 outbreak in Egypt.

Authors:  R Abu-Elyazeed; S el-Sharkawy; J Olson; B Botros; A Soliman; A Salib; C Cummings; R Arthur
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

5.  A model for the coupling of the Greater Bairam and local environmental factors in promoting Rift-Valley Fever epizootics in Egypt.

Authors:  H Gil; W A Qualls; C Cosner; D L DeAngelis; A Hassan; A M Gad; S Ruan; S R Cantrell; J C Beier
Journal:  Public Health       Date:  2015-08-19       Impact factor: 2.427

6.  Rift Valley fever virus epidemic in Kenya, 2006/2007: the entomologic investigations.

Authors:  Rosemary Sang; Elizabeth Kioko; Joel Lutomiah; Marion Warigia; Caroline Ochieng; Monica O'Guinn; John S Lee; Hellen Koka; Marvin Godsey; David Hoel; Hanafi Hanafi; Barry Miller; David Schnabel; Robert F Breiman; Jason Richardson
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

Review 7.  Molecular biology and genetic diversity of Rift Valley fever virus.

Authors:  Tetsuro Ikegami
Journal:  Antiviral Res       Date:  2012-06-16       Impact factor: 5.970

8.  A statistical model of Rift Valley fever activity in Egypt.

Authors:  John M Drake; Ali N Hassan; John C Beier
Journal:  J Vector Ecol       Date:  2013-12       Impact factor: 1.671

Review 9.  Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.

Authors:  Michele Bouloy; Ramon Flick
Journal:  Antiviral Res       Date:  2009-08-12       Impact factor: 5.970

10.  Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.

Authors:  Tetsuro Ikegami; Krishna Narayanan; Sungyong Won; Wataru Kamitani; C J Peters; Shinji Makino
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.